Tegal Corporation (NASDAQ: TGAL) today announced that is has become an industry partner of HealthTech Capital, one of Silicon Valley’s most prominent investing groups in emerging healthcare technology companies.

HealthTech Capital announced today that it invested over $300,000 as the lead Series A2 investor in Cadence Biomedical, Inc. The move underscores the growing trend of angel investor groups joining forces to fund innovative, early-stage companies

PharmaSecure Inc., a developer of pharmaceutical authentication technology, has raised $3.9 million from Eric Schmidt’s Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund. The infusion will be used to create applications to respond to the Government of India’s drug serialization requirements that go into effect next year. India has mandated that all drugs exported from the country must have unique serial numbers and barcodes.

HealthTech Capital, a Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market, announced today that it has closed two new investment deals.

By Don Ross, Managing Director & Founder, HealthTech Capital

Early-stage investors in traditional healthcare companies are certainly having a tough time these days. Many biotech, diagnostic and medical device firms have simply become too risky, as the current uncertain FDA regulatory environment increases cost and time to exit. 

Angels bring more than money; we've all heard that claim before, but Anne DeGheest has great results to show from her efforts mentoring entrepreneurs.